FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566517525> ?p ?o ?g. }

• W2566517525 abstract "Only 2% of brain metastases from solid tumors originate from breast cancer. However, this occurrence is relatively common in some subsets of breast cancer, including triple-negative and human epidermal growth factor receptor 2 protein (HER2) positive tumors. Among patients with advanced HER2-positive breast cancer, the incidence of brain metastases is in the range of 10–40%. Trastuzumab, a recombinant, humanized monoclonal IgG1 antibody that binds to extracellular subdomain IV of HER2/neu receptor, is used in HER2-positive breast cancer patients in adjuvant and metastatic setting. This therapy is associated with increased response rates, prolonged disease-free survival, and overall survival. Owing to its high molecular weight, penetration of trastuzumab into the central nervous system is extremely low, 1/420th of serum levels. Thus, trastuzumab is ineffective in treating established brain metastases and its preventive effect in the brain is likely indirect, by virtue of combating extracranial disease. New anti-HER2 agents with different mode of action and higher permeability to the central nervous system may have increased efficacy in the brain. The local management of brain metastases originating from breast cancer is dependent on patient performance status, the extent of brain involvement, and the coexistence of progressive extracranial disease, and includes surgery, stereotactic radiotherapy, and whole brain irradiation. There are no uniform recommendations for systemic therapy in HER2-positive breast cancer patients with brain metastases. According to recent ASCO guidelines, patients whose extracranial disease is not progressive at the time of brain relapse should not be switched to another systemic therapy, whereas in patients with progressive extracranial disease, other anti-HER2-targeted agents should be considered. A new area of preclinical and clinical investigations is prevention of brain metastases in high-risk groups of patients with both local and systemic therapies. The development of biomarkers predictive for brain relapse may allow selection of patients for such management and prompt new preventive and therapeutic strategies." @default.
• W2566517525 created "2017-01-06" @default.
• W2566517525 creator A5004874011 @default.
• W2566517525 creator A5045464653 @default.
• W2566517525 date "2016-01-01" @default.
• W2566517525 modified "2023-09-26" @default.
• W2566517525 title "Brain Metastases from Breast Cancer in Patients Receiving Trastuzumab" @default.
• W2566517525 cites W1967109331 @default.
• W2566517525 cites W1968934471 @default.
• W2566517525 cites W1976446970 @default.
• W2566517525 cites W1981701117 @default.
• W2566517525 cites W1988605901 @default.
• W2566517525 cites W1996258722 @default.
• W2566517525 cites W1998694514 @default.
• W2566517525 cites W1998765747 @default.
• W2566517525 cites W1998836381 @default.
• W2566517525 cites W2002710818 @default.
• W2566517525 cites W2004936781 @default.
• W2566517525 cites W2005834616 @default.
• W2566517525 cites W2008418515 @default.
• W2566517525 cites W2009694820 @default.
• W2566517525 cites W2013669698 @default.
• W2566517525 cites W2014053430 @default.
• W2566517525 cites W2014207192 @default.
• W2566517525 cites W2015213647 @default.
• W2566517525 cites W2020888019 @default.
• W2566517525 cites W2026266923 @default.
• W2566517525 cites W2029999856 @default.
• W2566517525 cites W2034430966 @default.
• W2566517525 cites W2040584772 @default.
• W2566517525 cites W2042701275 @default.
• W2566517525 cites W2042702856 @default.
• W2566517525 cites W2044579127 @default.
• W2566517525 cites W2045134790 @default.
• W2566517525 cites W2045324973 @default.
• W2566517525 cites W2063808087 @default.
• W2566517525 cites W2066477716 @default.
• W2566517525 cites W2066772614 @default.
• W2566517525 cites W2076209903 @default.
• W2566517525 cites W2088255940 @default.
• W2566517525 cites W2095682369 @default.
• W2566517525 cites W2096867589 @default.
• W2566517525 cites W2096884232 @default.
• W2566517525 cites W2098775844 @default.
• W2566517525 cites W2105963405 @default.
• W2566517525 cites W2109176076 @default.
• W2566517525 cites W2110444464 @default.
• W2566517525 cites W2118221532 @default.
• W2566517525 cites W2118600577 @default.
• W2566517525 cites W2119569174 @default.
• W2566517525 cites W2122489697 @default.
• W2566517525 cites W2126231395 @default.
• W2566517525 cites W2127515083 @default.
• W2566517525 cites W2127714076 @default.
• W2566517525 cites W2134031795 @default.
• W2566517525 cites W2138697863 @default.
• W2566517525 cites W2139085578 @default.
• W2566517525 cites W2139444209 @default.
• W2566517525 cites W2141393790 @default.
• W2566517525 cites W2141590659 @default.
• W2566517525 cites W2141712412 @default.
• W2566517525 cites W2143184226 @default.
• W2566517525 cites W2144124503 @default.
• W2566517525 cites W2144686284 @default.
• W2566517525 cites W2149550866 @default.
• W2566517525 cites W2157900261 @default.
• W2566517525 cites W2162453644 @default.
• W2566517525 cites W2164190676 @default.
• W2566517525 cites W2168814163 @default.
• W2566517525 cites W2171485586 @default.
• W2566517525 cites W2318605753 @default.
• W2566517525 doi "https://doi.org/10.1016/b978-0-12-803508-5.00016-0" @default.
• W2566517525 hasPublicationYear "2016" @default.
• W2566517525 type Work @default.
• W2566517525 sameAs 2566517525 @default.
• W2566517525 citedByCount "0" @default.
• W2566517525 crossrefType "book-chapter" @default.
• W2566517525 hasAuthorship W2566517525A5004874011 @default.
• W2566517525 hasAuthorship W2566517525A5045464653 @default.
• W2566517525 hasConcept C121608353 @default.
• W2566517525 hasConcept C126322002 @default.
• W2566517525 hasConcept C143998085 @default.
• W2566517525 hasConcept C2775930923 @default.
• W2566517525 hasConcept C2777863537 @default.
• W2566517525 hasConcept C2777982462 @default.
• W2566517525 hasConcept C2779786085 @default.
• W2566517525 hasConcept C509974204 @default.
• W2566517525 hasConcept C530470458 @default.
• W2566517525 hasConcept C71924100 @default.
• W2566517525 hasConceptScore W2566517525C121608353 @default.
• W2566517525 hasConceptScore W2566517525C126322002 @default.
• W2566517525 hasConceptScore W2566517525C143998085 @default.
• W2566517525 hasConceptScore W2566517525C2775930923 @default.
• W2566517525 hasConceptScore W2566517525C2777863537 @default.
• W2566517525 hasConceptScore W2566517525C2777982462 @default.
• W2566517525 hasConceptScore W2566517525C2779786085 @default.
• W2566517525 hasConceptScore W2566517525C509974204 @default.
• W2566517525 hasConceptScore W2566517525C530470458 @default.
• W2566517525 hasConceptScore W2566517525C71924100 @default.
• W2566517525 hasLocation W25665175251 @default.

• next